Other
cell-free dNA
cell-free dNA is an intervention with 3 clinical trials. Currently 2 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Active Trials
2(67%)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
3
all time
Status Distribution
Active(2)
Other(1)
Detailed Status
Recruiting2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting267%
unknown133%
Recent Activity
2 active trials
Showing 3 of 3
recruitingnot_applicable
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NCT05676450
recruiting
Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
NCT06679257
unknown
Biomarkers for Diagnosis, Prognosis, and Targeted Therapy After Heart Transplantation
NCT06064123
Clinical Trials (3)
Showing 3 of 3 trials
NCT05676450Not Applicable
Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas
NCT06679257
Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO
NCT06064123
Biomarkers for Diagnosis, Prognosis, and Targeted Therapy After Heart Transplantation
All 3 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 3